Wolverine Trading, LLC Durect Corp Transaction History

Wolverine Trading, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$1.6 - $2.35 $40,172 - $59,003	-25,108 Reduced 68.96%	11,303 $20,000
Q2 2020 Aug 13, 2020	SELL	$1.33 - $2.76 $5,635 - $11,694	-4,237 Reduced 10.42%	36,411 $91,000
Q1 2020 May 11, 2020	SELL	$0.97 - $2.85 $4,309 - $12,662	-4,443 Reduced 9.85%	40,648 $61,000
Q4 2019 Feb 12, 2020	BUY	$1.69 - $3.8 $76,203 - $171,345	45,091 New	45,091 $159,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $210M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.